Abstract:Abstract Background Prostate cancer (PCa) and benign prostate hyperplasia (BPH) are commonly encountered diseases in elderly males. The two diseases have some commonalities: both are growth depend on hormone and respond to antiandrogen therapy. Some studies have shown that genetic factors are responsible for the occurrences of both diseases. There may be a correlation between BPH and PCa. Methods The GEO database can help determine the differentially expressed genes (DEGs) between BPH and PCa. Gene Ontology (GO) term enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were utilized to find pathways in which the DEGs were enriched. The STRING database can provide a protein–protein interaction (PPI) network, and Cytoscape software can find hub genes in PPI network. GEPIA can be used to analyze expression and survival data for hub genes. R software was used to progress regression analysis, decision curve analysis and built nomograph. UALCAN and The Human Protein Atlas was utilized to test the results. Finally, we made clinical and cell experiments to verify the results. Results Sixty DEGs, consisting of 15 up-regulated and 45 down-regulated genes, were found based on the GEO database. Using Cytoscape, we found 7 hub gene in the PPI network. The hub gene expression was tested on TCGA database. Except CXCR4, all hub genes expressed differently between tumor and normal samples. Meanwhile, all hub genes exclude CXCR4 has diagnostic value in predicting PCa and their mutations are risk factors leading to PCa. The expression of CSRP1 , MYL9 and SNAI2 changed in different tumor stage. CSRP1 and MYH11 could affect the disease-free survival (DFS). The same results reflected in different database. In addition, we also chose three hub gene, MYC , MYL9 , and SNAI2 , to validate their functions in clinical specimens and cells. Conclusion These identified hub genes can help us to understand the process and mechanism by which BPH develops into PCa and provide achievable targets for predicting which BPH patients may later develop PCa.

Identification and functional activity of Nik related kinase (NRK) in benign hyperplastic prostate

Identification Of Key Genes And Pathways In Benign Prostatic Hyperplasia

Nrf2-mediated macrophage function in benign prostatic hyperplasia: Novel molecular insights and implications

AKR1B10 expression in benign prostatic hyperplasia and its related mechanism

THE RELATIONSHIP OF THE PROLIFERATION AND PHENOTYPIC MODULATION OF THE STROMAL CELLS AND THE EXPRESSION OF ESTROGEN RECEPTOR α IN BENIGN PROSTATIC HYPERPLASIA

NELL2 Modulates Cell Proliferation and Apoptosis via ERK Pathway in the Development of Benign Prostatic Hyperplasia.

Genome-wide association study identifies a role for the progesterone receptor in benign prostatic hyperplasia risk

EGR1 Promotes Proliferation in Prostatic Hyperplasia Epithelial BPH-1 Cells

Relationship between the Expression of Estrogen Receptor α and Basal Cell Dedifferentiation in Benign Prostatic Hyperplasia

Identification of hub genes and their clinical value for predicting the development of prostate cancer from benign prostate hyperplasia by bioinformatic analysis

Regulation of CCN1 on angiogenesis in benign prostatic hyperplasia

Identification of a Novel Therapeutic Candidate, NRK, in Primary Cancer-Associated Fibroblasts of Lung Adenocarcinoma Microenvironment

Androgen regulated HN1 leads proteosomal degradation of androgen receptor (AR) and negatively influences AR mediated transactivation in prostate cells

CHRDL1, NEFH, TAGLN and SYNM as novel diagnostic biomarkers of benign prostatic hyperplasia and prostate cancer

Integrating spatial transcriptomics and single-cell RNA-sequencing reveals the alterations in epithelial cells during nodular formation in benign prostatic hyperplasia

CSNK1D-mediated phosphorylation of HNRNPA2B1 induces miR-25-3p/miR-93-5p maturation to promote prostate cancer cell proliferation and migration through m6A-dependent manner

Integrative exploration of the mutual gene signatures and immune microenvironment between benign prostate hyperplasia and castration-resistant prostate cancer

Immune Infiltration Pattern Associated with Diagnosis and Development in Benign Prostatic Hyperplasia

high expression of NF-κB inducing kinase in the bulge region of hair follicle induces tumor

Proteomics Analysis of the Interactome of N-myc Downstream Regulated Gene 1 and Its Interactions with the Androgen Response Program in Prostate Cancer Cells

NOSTRIN is involved in benign prostatic hyperplasia via inhibition of proliferation, oxidative stress, and inflammation in prostate epithelial cells